Ketamine Completed Phase 4 Trials for Major Depressive Disorder (MDD) / Suicidal Thoughts Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01700829Ketamine in the Treatment of Suicidal Depression
NCT00419003Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
NCT01507181Ketamine For Suicidal Ideation